HUAREN MEDICAL TECHNOLOGY
NEWS
Company News
21
2022-01
New discovery! Alzheimer's drug has efficacy in inhibiting cancer progression!
Glioblastoma multiforme is the most common primary brain cancer in adults and has a low chance of cure, almost always recurring after surgical resection, and a high level of resistance to existing treatments. However, it is possible that the immunosuppressive tumour microenvironment hides previously undiscovered therapeutic targets: it has been found that a drug used to limit the pathological accumulation of amyloid-β in the brains of Alzheimer's disease patients, MK-8931, triggers phagocytosis of the associated macrophages and kills the cancer cells, and has now been shown in a preclinical mouse model to achieving tumour control.
View More21
2022-01
On January 18, 2022, Chen Hong, Deputy Secretary of the Party Group of Nanning Municipal Government and Executive Deputy Director of the Administrative Committee of WuXiang New Area (Nanning Pilot Free Trade Zone), Li Ran, Deputy Secretary of the CPC Committee, Secretary of the Party Group of Nanning Municipal Government, Deputy Mayor, Acting Mayor of Nanning City Liangqing District, and the Development, Reform, Investment and Promotional Bureau of the Administrative Committee of WuXiang New Area (Nanning Pilot Free Trade Zone), the Bureau of New Economy Development, the Construction Bureau of the Administrative Committee, the government of Liangqing District, the Administrative Committee of Comprehensive Free Trade Zone, and the Five Elephants Investment Company and other relevant responsible comrades went to the Hualen Medical Joint Research & Experiment Center for research and investigation and to investigate on-site Hualen Group's development situation, technological innovation, and industry layout, and the group leaders were accompanied by them throughout the whole trip.
View More15
2022-01
On January 12, 2022, Xu Yan, deputy director of the People's Government of Jiangnan District, Nanning City, and relevant responsible comrades of the Urban Economic and Information Bureau, Health Bureau, Investment Promotion Center, Hui Jiangnan Investment Company and Nanning Industry Investment and Intelligence Company visited and investigated Huaren Medical Joint Research and Experimental Center, and investigated Huaren Group's development, technological innovation and industrial layout, and the leaders of the Group accompanied the whole process.
View More08
2022-01
New study finds treatment for drug-resistant inflammatory bowel disease
Friedrich's research team recently published their latest research paper in the prestigious medical journal Nature Medicine, revealing the role of the interleukin-1-fibroblast-neutrophil signalling pathway in drug-resistant inflammatory bowel disease, opening up a new avenue for the development of targeted therapeutic strategies for it.
View More31
2021-12
The Legendary Rise of Exosomes (Basic)
Exosomes are treated as "rubbish" after decades of humiliation, in recent years, finally raised eyebrows, fire a mess, like a black horse out of the reins, in the field of drug delivery, liquid biopsy, oncology treatment, medical beauty and other areas of the emergence of the number of articles related to the study has been a blowout growth in the world's scientific research experts have piled up here, the exosome has become a major hot spot in life science and basic medical research. Exosomes have become a major hotspot in life science and basic medical research. What is the secret behind this flourishing scene?
View More25
2021-12
Scientific research captures chemokine CXCL9, the culprit in human ageing
It is well known that the inflammatory response in the body increases with age, and conditions such as arthritis, vasculitis, bronchitis, etc. suggest that the body is aging, and diseases can ensue. Recently, researchers have identified a group of cytokines that are associated with declining health in aging, with the chemokine CXCL9 playing a huge role in driving the inflammatory response in the body.
View MoreSUBSCRIPTION INFORMATION
We will send you real-time information regularly!
Guangxi Huaren Medical Technology Group Co., Ltd.
Tel: 400-138-8669/ 0771-611-0603
Address: 15th Floor, Building A, Biyuan Center, Wuxiang New District, Nanning City, China (Guangxi) Pilot Free Trade Zone
Huaren Medical Technology
Huaren Medical Research
Hua Ren Cell said